指南与共识泌尿生殖与妇科肿瘤放疗放疗物理与技术

基于前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描的前列腺切除术后挽救性放疗临床靶区勾画指南:PERYTON指南

Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Based Clinical Target Volume Delineation Guideline for Postprostatectomy Salvage Radiation Therapy: The PERYTON Guideline.
指南 / 共识 · Int J Radiat Oncol Biol Phys · 2023-09-18

该指南基于9家荷兰中心回顾性纳入的83例前列腺切除术后生化复发患者的PSMA PET/CT,由专家核医学医师中心审阅识别93处局部复发,对GFRU-CTF逐边界评估并调整形成PERYTON-CTV,使PSMA PET/CT检出局部复发的覆盖率从67%提高至96%,同时较GFRU-CTV减少25%,平均DSC为0.82(范围0.81-0.83)。

要点

  • PERYTON-CTV将PSMA PET/CT检出局部复发的覆盖从67%提高至96%。
  • PERYTON-CTV较GFRU-CTV减少25%,平均DSC为0.82(范围0.81-0.83)。
  • 该指南基于9家荷兰中心83例PSMA PET/CT的93处局部复发中心审阅结果。

核心结论

  • PERYTON-CTV在各参与中心间高度可重复,确保覆盖96%的局部复发,同时较GFRU-CTV减少25%。

研究设计与样本

  • 回顾性纳入9家荷兰中心前列腺切除术后PSMA PET/CT疑似局部复发的患者,匿名扫描由专家核医学医师中心审阅;对GFRU-CTV逐边界评估并调整,与参与中心放射肿瘤科医生讨论达成最终共识。
  • 要求参与中心按新PERYTON-CTV勾画3例新病例,并用Dice相似系数(DSC)评估提交的勾画。

主要发现

  • 中心审阅后,在83例PSMA PET/CT上识别出93处局部复发。
  • 与GFRU-CTV相比,所提CTV定义将PSMA PET/CT检出局部复发的覆盖从67%提高至96%,同时使GFRU-CTV减少25%。
  • 新CTV高度可重复,平均DSC为0.82(范围0.81-0.83)。

关键数值与推荐

  • 与GFRU-CTV相比,PERYTON-CTV对PSMA PET/CT检出局部复发的覆盖从67%提高至96%。
  • PERYTON-CTV较GFRU-CTV减少25%。
  • PERYTON-CTV的平均DSC为0.82(范围0.81-0.83)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) scan is the standard imaging procedure for biochemical recurrent prostate cancer postprostatectomy because of its high detection rate at low serum prostate-specific antigen levels. However, existing guidelines for clinical target volume (CTV) in prostate bed salvage external beam radiation therapy (sEBRT) are primarily based on experience-based clinical consensus and have been validated using conventional imaging modalities. Therefore, this study aimed to optimize CTV definition in sEBRT by using PSMA PET/CT-detected local recurrences (LRs). METHODS AND MATERIALS: Patients with suspected LR on PSMA PET/CT postprostatectomy were retrospectively enrolled in 9 Dutch centers. Anonymized scans were centrally reviewed by an expert nuclear medicine physician. Each boundary of the CTV guideline from the Groupe Francophone de Radiothérapie en Urologie (GFRU) was evaluated and adapted to improve the accuracy and coverage of the area at risk of LR (CTV) on PSMA PET/CT. The proposed CTV adaptation was discussed with the radiation oncologists of the participating centers, and final consensus was reached. To assess reproducibility, the participating centers were asked to delineate 3 new cases according to the new PERYTON-CTV, and the submitted contours were evaluated using the Dice similarity coefficient (DSC). RESULTS: After central review, 93 LRs were identified on 83 PSMA PET/CTs. The proposed CTV definition improved the coverage of PSMA PET/CT-detected LRs from 67% to 96% compared with the GFRU-CTV, while reducing the GFRU-CTV by 25%. The new CTV was highly reproducible, with a mean DSC of 0.82 (range, 0.81-0.83). CONCLUSIONS: This study contributes to the optimization of CTV definition in postprostatectomy sEBRT by using the pattern of LR detected on PSMA PET/CT. The PERYTON-CTV is highly reproducible across the participating centers and ensures coverage of 96% LRs while reducing the GFRU-CTV by 25%.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Staal FHE, Janssen J, Oprea-Lager DE, et al. Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Based Clinical Target Volume Delineation Guideline for Postprostatectomy Salvage Radiation Therapy: The PERYTON Guideline. Int J Radiat Oncol Biol Phys. 2023. PMID: 37729971. doi:10.1016/j.ijrobp.2023.09.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。